Showing 5141-5150 of 5956 results for "".
- Novartis Withdraws Marketing Application of Dry Eye Drug Xiidra in Europehttps://modernod.com/news/novartis-pulls-eu-filing-seeking-approval-of-xiidra-for-dry-eye-disease/2477942/Novartis has decided to withdraw its marketing application seeking approval of dry eye drug Xiidra (lifitegrast) in Europe. The decision comes after the European Medicines Agency (EMA) said the drug’s benefits did not outweigh its risks. Novartis pulled the application on June 18 after the
- DORC Launches New Range of EVA EquiPhaco Needles and Sleeveshttps://modernod.com/news/dorc-launches-new-range-of-eva-equiphaco-needles-and-sleeves/2477940/DORC announced the launch of a new range of EVA EquiPhaco needles and sleeves, which are designed to deliver superior ultrasound efficiency, improved anterior chamber stability, and easier sleeve positioning. T
- 2021 ASCRS Annual Meeting Pushed Back to Augusthttps://modernod.com/news/2021-ascrs-annual-meeting-pushed-back-to-august/2477939/ASCRS announced that it is pushing back its 2021 annual meeting in San Francisco from April to August. “This decision was thoroughly researched and discussed, and when weighed against the risks of possibly losing another meeting to the coronavirus, we felt we had no other alternative
- Visual Clinic’s Patient Flow Management Solution Aims to Help Eye Care Clinics Operate Post-COVID-19https://modernod.com/news/visual-clinics-patient-flow-management-solution-aims-to-help-eye-care-clinics-operate-post-covid-19/2477935/Visual Clinic is offering a solution designed to help eye care clinics achieve better patient flow. The software aims to help practices run at peak efficiency, improve the patient experience, maximize practice resources, and keep overhead costs low while optimizing revenue. Additionally
- CDC Broadens Guidance on Americans Facing Risk of Severe COVID-19https://modernod.com/news/cdc-broadens-guidance-on-americans-facing-risk-of-severe-covid-19/2477936/The Centers for Disease Control and Prevention on Thursday broadened its warning about who is at risk of developing severe disease from COVID-19 infection, suggesting even younger people who are obese or have other health conditions can become seriously ill if they contract the virus, according t
- Saunders Finds Life After Allergan on Board at Newly IPO’ed BridgeBiohttps://modernod.com/news/saunders-finds-life-after-allergan-on-board-at-newly-ipoed-bridgebio/2477933/Less than 2 months after Allergan was officially taken in by AbbVie, its last helmsman, Brent Saunders, has landed on the board of a young biotech that recently pulled off a large IPO, according to a FiercePharma
- AMA Pushes for Federal Intervention to Reform Prior Authorizationhttps://modernod.com/news/ama-pushes-for-federal-intervention-to-reform-prior-authorization/2477934/Docs say health plans have made little progress toward streamlining prior authorization—despite pledging to do so 2 years ago, according to a FierceHealthcare report.
- Sight Sciences Names New Chief Operating Officer and General Counselhttps://modernod.com/news/sight-sciences-names-new-chief-operating-officer-and-general-counsel/2477930/Sight Sciences announced two key hires: Sam Park, joining as Chief Operating Officer, and Jeremy Hayden, who joins as General Counsel and Chief Compliance Officer. “We are excited to be able to add leaders with the outstanding track records of Sam and Jeremy as Sight Sciences continu
- Sanofi Sees Potential Approval of COVID-19 Vaccine in First Half of 2021https://modernod.com/news/sanofi-sees-potential-approval-of-covid-19-vaccine-in-first-half-of-2021/2477923/Sanofi said Tuesday that it expects potential approval of a COVID-19 vaccine being jointly developed with GlaxoSmithKline in the first half of next year, brought forward from an earlier estimate of the second half of 2021. A phase 1/2 study of the recombinant protein-based vaccine approach, whic
- UK to Test Weekly, Swabless COVID-19 Screening for Health Care Workers, Students and Morehttps://modernod.com/news/uk-to-test-weekly-swabless-covid-19-screening-for-health-care-workers-students-and-more/2477918/The UK government will begin testing a new, swabless coronavirus test, designed to be completed at home on a weekly basis by spitting into a collection tube, according to a FierceBiotech